Why are tick-borne illnesses on the rise across the U.S. and beyond, and what can we do to control tick outbreaks?

It is understood that Care Access was helping Pfizer target ... bites. Lyme disease is the most common vector-borne illness in the Northern Hemisphere, and causes a characteristic rash that ...

Her primary doctor referred her to a disease specialist at Children’s Hospital. The specialist informed her that the bull’s-eye rash doesn’t always develop on those who contract Lyme Disease ...

Most typically, the rash expands and then fades within a few weeks after the bite. There is a blood test for Lyme Disease, but it is not perfect. The test generally produces positive results in the ...

which makes up part of the protective intestinal mucus layer, fuels disease-causing bacteria in the gut. The findings suggest a potential treatment target for ...

Feb. 7, 2025 — Women who have experienced pregnancy complications have an increased risk of cardiovascular disease ... A New Therapeutic Target for a Lethal Form of Heart Failure: ALPK2 Jan ...

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

Data are accumulating that emphasize the important role of the intestinal barrier and intestinal permeability for health and disease. However, these terms are poorly defined, their assessment is a ...

Akcea meanwhile licensed another mid-stage antisense drug against a third cardiovascular disease target – ANGPTL3 – to Pfizer in 2019 in a deal that included a $250 million upfront payment.

Sometimes, it can pass on Lyme disease. Most wood tick bites are harmless ... If the tick transferred a disease, a rash will occur. It will appear in the next 4 weeks.

Bumps might develop shortly after contact with an allergen, resulting in a red, itchy rash on the legs. Itchy legs can be an early warning sign of diabetes. And if you’ve been previously ...

Oleogel-S10 is an effective and well-tolerated long-term treatment for epidermolysis bullosa, including patients with severe forms of the disease.